Floyd L. Wormley Jr. to Fungal Vaccines
This is a "connection" page, showing publications Floyd L. Wormley Jr. has written about Fungal Vaccines.
Connection Strength
1.795
-
Leopold Wager CM, Wormley FL. Is Development of a Vaccine against Cryptococcus neoformans Feasible? PLoS Pathog. 2015 Jun; 11(6):e1004843.
Score: 0.507
-
Chaturvedi AK, Hameed RS, Wozniak KL, Hole CR, Leopold Wager CM, Weintraub ST, Lopez-Ribot JL, Wormley FL. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 2014; 9(8):e104316.
Score: 0.478
-
Chaturvedi AK, Wormley FL. Cryptococcus antigens and immune responses: implications for a vaccine. Expert Rev Vaccines. 2013 Nov; 12(11):1261-72.
Score: 0.453
-
Zhai B, Wozniak KL, Masso-Silva J, Upadhyay S, Hole C, Rivera A, Wormley FL, Lin X. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio. 2015 Oct 06; 6(5):e01433-15.
Score: 0.129
-
Chaturvedi AK, Weintraub ST, Lopez-Ribot JL, Wormley FL. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics. 2013 Dec; 13(23-24):3429-41.
Score: 0.114
-
Wormley FL, Cox GM, Perfect JR. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain. Microb Pathog. 2005 Feb-Mar; 38(2-3):113-23.
Score: 0.062
-
C?rdenas-Freytag L, Steele C, Wormley FL, Cheng E, Clements JD, Fidel PL. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G). Med Mycol. 2002 Jun; 40(3):291-9.
Score: 0.051